{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:24:33Z","timestamp":1758273873456,"version":"3.41.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41409-025-02560-y","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T11:23:27Z","timestamp":1743333807000},"page":"773-778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Superior outcomes of haploidentical hematopoietic cell transplantation over chemotherapy in AML patients 55 years or older"],"prefix":"10.1038","volume":"60","author":[{"given":"Lin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhile","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8704-1571","authenticated-orcid":false,"given":"Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huarui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diange","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3706-4959","authenticated-orcid":false,"given":"Yishan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8548-2832","authenticated-orcid":false,"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2723-1621","authenticated-orcid":false,"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,30]]},"reference":[{"key":"2560_CR1","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1200\/JCO.2014.55.1564","volume":"32","author":"HD Klepin","year":"2014","unstructured":"Klepin HD, Rao AV, Pardee TS. Acute myeloid leukemia and myelodysplastic syndromes in older adults. J Clin Oncol. 2014;32:2541\u201352. https:\/\/doi.org\/10.1200\/JCO.2014.55.1564.","journal-title":"J Clin Oncol"},{"key":"2560_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102549","volume":"71","author":"MS Linet","year":"2024","unstructured":"Linet MS, Curtis RE, Schonfeld SJ, Vo JB, Morton LM, Dores GM. Survival of adult AML patients treated with chemotherapy in the U.S. population by age, race and ethnicity, sex, calendar-year period, and AML subgroup, 2001-2019. EClinicalMedicine. 2024;71:102549 https:\/\/doi.org\/10.1016\/j.eclinm.2024.102549.","journal-title":"EClinicalMedicine"},{"key":"2560_CR3","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1016\/S2352-3026(15)00148-9","volume":"2","author":"J Versluis","year":"2015","unstructured":"Versluis J, Hazenberg CL, Passweg JR, van Putten WL, Maertens J, Biemond BJ, et al. Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis. Lancet Haematol. 2015;2:e427\u2013436. https:\/\/doi.org\/10.1016\/S2352-3026(15)00148-9.","journal-title":"Lancet Haematol"},{"key":"2560_CR4","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1200\/jco.2015.62.7273","volume":"33","author":"SM Devine","year":"2015","unstructured":"Devine SM, Owzar K, Blum W, Mulkey F, Stone RM, Hsu JW, et al. Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)\/Blood and Marrow Transplant Clinical Trial Network 0502. J Clin Oncol. 2015;33:4167\u201375. https:\/\/doi.org\/10.1200\/jco.2015.62.7273.","journal-title":"J Clin Oncol"},{"key":"2560_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13045-016-0347-1","volume":"9","author":"A Shimoni","year":"2016","unstructured":"Shimoni A, Labopin M, Savani B, Volin L, Ehninger G, Kuball J, et al. Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantation. J Hematol Oncol. 2016;9:118 https:\/\/doi.org\/10.1186\/s13045-016-0347-1.","journal-title":"J Hematol Oncol"},{"key":"2560_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-015-0182-9","volume":"8","author":"YJ Chang","year":"2015","unstructured":"Chang YJ, Zhao XY, Xu LP, Zhang XH, Wang Y, Han W, et al. Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets. J Hematol Oncol. 2015;8:84 https:\/\/doi.org\/10.1186\/s13045-015-0182-9.","journal-title":"J Hematol Oncol"},{"key":"2560_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01072-0","volume":"14","author":"Y Ye","year":"2024","unstructured":"Ye Y, Labopin M, Chen J, Wu D, Gedde-Dahl T Sr, Blaise D, et al. Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT. Blood Cancer J. 2024;14:85 https:\/\/doi.org\/10.1038\/s41408-024-01072-0.","journal-title":"Blood Cancer J"},{"key":"2560_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-020-00882-6","volume":"13","author":"J Sanz","year":"2020","unstructured":"Sanz J, Galimard JE, Labopin M, Afanasyev B, Angelucci E, Ciceri F, et al. Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT. J Hematol Oncol. 2020;13:46 https:\/\/doi.org\/10.1186\/s13045-020-00882-6.","journal-title":"J Hematol Oncol"},{"key":"2560_CR9","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/cncr.32629","volume":"126","author":"NC Gorin","year":"2020","unstructured":"Gorin NC, Labopin M, Blaise D, de Groot M, Soci\u00e9 G, Bourhis JH, et al. Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Cancer. 2020;126:1004\u201315. https:\/\/doi.org\/10.1002\/cncr.32629.","journal-title":"Cancer"},{"key":"2560_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, et al. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. N Engl J Med. 2020;383:617\u201329. https:\/\/doi.org\/10.1056\/NEJMoa2012971.","journal-title":"N Engl J Med"},{"key":"2560_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377. https:\/\/doi.org\/10.1182\/blood.2022016867.","journal-title":"Blood"},{"key":"2560_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s11912-023-01450-0","volume":"25","author":"M Zimmer","year":"2023","unstructured":"Zimmer M, Kadia T. Approach to the Older Patient with Acute Myeloid Leukemia. Curr Oncol Rep. 2023;25:1203\u201311. https:\/\/doi.org\/10.1007\/s11912-023-01450-0.","journal-title":"Curr Oncol Rep"},{"key":"2560_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ajh.24246","volume":"91","author":"H Kantarjian","year":"2016","unstructured":"Kantarjian H. Acute myeloid leukemia-major progress over four decades and glimpses into the future. Am J Hematol. 2016;91:131\u201345. https:\/\/doi.org\/10.1002\/ajh.24246.","journal-title":"Am J Hematol"},{"key":"2560_CR14","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","volume":"107","author":"FR Appelbaum","year":"2006","unstructured":"Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, Godwin JE, et al. Age and acute myeloid leukemia. Blood. 2006;107:3481\u20135. https:\/\/doi.org\/10.1182\/blood-2005-09-3724.","journal-title":"Blood"},{"key":"2560_CR15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00277-015-2351-x","volume":"94","author":"BC Medeiros","year":"2015","unstructured":"Medeiros BC, Satram-Hoang S, Hurst D, Hoang KQ, Momin F, Reyes C. Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States. Ann Hematol. 2015;94:1127\u201338. https:\/\/doi.org\/10.1007\/s00277-015-2351-x.","journal-title":"Ann Hematol"},{"key":"2560_CR16","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1182\/bloodadvances.2017015222","volume":"2","author":"S Vasu","year":"2018","unstructured":"Vasu S, Kohlschmidt J, Mr\u00f3zek K, Eisfeld AK, Nicolet D, Sterling LJ, et al. Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission. Blood Adv. 2018;2:1645\u201350. https:\/\/doi.org\/10.1182\/bloodadvances.2017015222.","journal-title":"Blood Adv"},{"key":"2560_CR17","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.bbmt.2011.06.005","volume":"17","author":"SS Farag","year":"2011","unstructured":"Farag SS, Maharry K, Zhang MJ, P\u00e9rez WS, George SL, Mr\u00f3zek K, et al. Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant. 2011;17:1796\u2013803. https:\/\/doi.org\/10.1016\/j.bbmt.2011.06.005.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2560_CR18","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1038\/s41375-019-0477-x","volume":"33","author":"C Ustun","year":"2019","unstructured":"Ustun C, Le-Rademacher J, Wang HL, Othus M, Sun Z, Major B, et al. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study. Leukemia. 2019;33:2599\u2013609. https:\/\/doi.org\/10.1038\/s41375-019-0477-x.","journal-title":"Leukemia"},{"key":"2560_CR19","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1182\/bloodadvances.2021004435","volume":"6","author":"R Devillier","year":"2022","unstructured":"Devillier R, Forcade E, Garnier A, Guenounou S, Thepot S, Guillerm G, et al. In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study. Blood Adv. 2022;6:1804\u201312. https:\/\/doi.org\/10.1182\/bloodadvances.2021004435.","journal-title":"Blood Adv"},{"key":"2560_CR20","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1158\/1078-0432.ccr-23-3673","volume":"30","author":"A Bazarbachi","year":"2024","unstructured":"Bazarbachi A, Labopin M, Moukalled N, Kr\u00f6ger N, Rautenberg C, Schetelig J, et al. Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study. Clin Cancer Res. 2024;30:1778\u201387. https:\/\/doi.org\/10.1158\/1078-0432.ccr-23-3673.","journal-title":"Clin Cancer Res"},{"key":"2560_CR21","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/ajh.27342","volume":"99","author":"Y Ye","year":"2024","unstructured":"Ye Y, Labopin M, Gerard S, Yakoub-Agha I, Blau IW, Aljurf M, et al. Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Am J Hematol. 2024;99:1290\u20139. https:\/\/doi.org\/10.1002\/ajh.27342.","journal-title":"Am J Hematol"},{"key":"2560_CR22","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","volume":"130","author":"L Muffly","year":"2017","unstructured":"Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, et al. Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States. Blood. 2017;130:1156\u201364. https:\/\/doi.org\/10.1182\/blood-2017-03-772368.","journal-title":"Blood"},{"key":"2560_CR23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41409-023-02027-y","volume":"58","author":"E Maffini","year":"2023","unstructured":"Maffini E, Ngoya M, Galimard JE, Harbi S, Kr\u00f6ger N, Platzbecker U, et al. Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2023;58:1033\u201341. https:\/\/doi.org\/10.1038\/s41409-023-02027-y.","journal-title":"Bone Marrow Transplant"},{"key":"2560_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-018-0598-0","volume":"11","author":"N Santoro","year":"2018","unstructured":"Santoro N, Labopin M, Giannotti F, Ehninger G, Niederwieser D, Brecht A, et al. Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT. J Hematol Oncol. 2018;11:55 https:\/\/doi.org\/10.1186\/s13045-018-0598-0.","journal-title":"J Hematol Oncol"},{"key":"2560_CR25","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.bbmt.2017.09.005","volume":"24","author":"SO Ciurea","year":"2018","unstructured":"Ciurea SO, Shah MV, Saliba RM, Gaballa S, Kongtim P, Rondon G, et al. Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome. Biol Blood Marrow Transplant. 2018;24:1232\u20136. https:\/\/doi.org\/10.1016\/j.bbmt.2017.09.005.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2560_CR26","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41409-022-01650-5","volume":"57","author":"JE Maakaron","year":"2022","unstructured":"Maakaron JE, Zhang MJ, Chen K, Abhyankar S, Bhatt VR, Chhabra S, et al. Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis. Bone marrow Transplant. 2022;57:911\u20137. https:\/\/doi.org\/10.1038\/s41409-022-01650-5.","journal-title":"Bone marrow Transplant"},{"key":"2560_CR27","doi-asserted-by":"publisher","unstructured":"Vo PT, Sandmaier BM, Othus M, Ali N, Rodr\u00edguez-Arbol\u00ed E, Orvain C et al. Relationship between age, conditioning intensity, and outcome after allografting in adults age \u226560 years with AML. Bone Marrow Transplant. 2025, https:\/\/doi.org\/10.1038\/s41409-025-02516-2.","DOI":"10.1038\/s41409-025-02516-2"},{"key":"2560_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","volume":"14","author":"XH Zhang","year":"2021","unstructured":"Zhang XH, Chen J, Han MZ, Huang H, Jiang EL, Jiang M, et al. The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol. 2021;14:145 https:\/\/doi.org\/10.1186\/s13045-021-01159-2.","journal-title":"J Hematol Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02560-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02560-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02560-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:18:19Z","timestamp":1749557899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02560-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,30]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2560"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02560-y","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2025,3,30]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Ethical approval was obtained from the Clinical Research Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine and Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, China. Informed consent was obtained from all participants prior to their involvement in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}